OncoSynergy Competitors and Similar CompaniesClear all
Celltrion Healthcare's competitors and similar companies include Biocon and Allogene Therapeutics.
 Celltrion Healthcare Celltrion Healthcare is a biopharmaceutical company specializing in oncology, influenza, psoriasis, and arthritis., |  Allogene Therapeutics Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer. | ||
Founding Date | Founding Date 2002 | Founding Date 1978 | Founding Date 2018 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Incheon, KR HQ | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations South San Francisco, US HQ |
Employees | Employees 6301% increase | Employees 16,5612% increase | Employees 2263% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) ₩2t (FY, 2022) | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) N/A |
Cost of goods | Cost of goods ₩1.4t (FY, 2022) | Cost of goods ₹56.9b (FY, 2026) | Cost of goods N/A |
Gross profit | Gross profit ₩664.7b (FY, 2022) | Gross profit ₹115.8b (FY, 2026) | Gross profit N/A |
Net income | Net income ₩147.2b (FY, 2022) | Net income ₹3.7b (FY, 2026) | Net income ($190.9m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Biocon
HQ
Bengaluru, IN
Employees
16,561↑ 2% increase
Biocon is a company that develops and manufactures biopharmaceutical products.
View companyAllogene Therapeutics
HQ
South San Francisco, US
Employees
226↓ 3% decrease
Allogene Therapeutics is a clinical-stage biotechnology company developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer.
View company